Category: Diagnostic Technologies

Diagnostic Technologies

Proscia Releases New Version of Pathology Platform

The update integrates artificial intelligence into the system architecture to assist with case review, biomarker discovery, and laboratory operations.

Diagnostic Technologies

Blood Test Gains FDA Approval for First-Line HER2-Mutant Lung Cancer Treatment Selection

Guardant360 CDx can now identify patients eligible for zongertinib, the first targeted therapy approved as an initial treatment option for HER2-mutant advanced non-small cell lung cancer.

Diagnostic Technologies

Experts Call for End to Routine ‘Corrected’ Calcium Reporting

A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.

Anatomic Pathology

FDA Grants Breakthrough Designation to AI Bladder Cancer Prognostic Test

The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.

Digital Pathology

Tempus Launches Open-Source Digital Pathology Consortium with Major Medical Centers

The initiative aims to standardize digital pathology through an open-source platform and image management system.

Clinical Chemistry

Saliva Test May Identify Acute Sleep Deprivation

Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.

Flow Cytometry

Bio-Rad Expands Antibody Labeling Kits for Flow Cytometry and Western Blot

Bio-Rad has expanded its TrailBlazer StarBright Dye Label Kits to 32 options, now available in Europe for flow cytometry and fluorescent western blot applications, according to the company.

Hematology & Serology

Sysmex America Launches New Hematology Solution for Clinical Labs

The XR-Series features higher throughput and enhanced analytics to streamline daily laboratory operations.

Immunoassay

Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?

Biomarkers in midlife adults without dementia may be linked to the earliest signs of waning cognition, researchers found.

Mass Spectrometry

Agilent Launches New Trace Element Analysis System for Laboratories

The new triple quadrupole mass spectrometry system aims to increase sample throughput and simplify interference removal.

Microbiology

CirrusDx Adds Lab Testing for Recently Approved UTI Antibiotic

The new capability helps clinicians determine if a patient's infection will respond to gepotidacin before prescribing the treatment.

Molecular Diagnostics

Study Shows Blood Test Predicts Breast Cancer Recurrence Years Before Clinical Symptoms

Monitoring circulating tumor DNA dynamics outperformed standard markers for predicting survival and relapse in early-stage patients.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Urine Metabolite Test Shows Potential for Autism Risk Screening

The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.